389470.KS · 인벤티지랩

South Korea · RS rating 12 · As of 2026-10-14

Price26,950.00 KRW
1-day change+13.7%
RS rating (overall / 1M / 3M / 12M)12 / 78 / 7 / 20
StageDeclining
Composite / Minervini / CANSLIM score18 / 4 / 17
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-178.7%
Sales growth Q/Q-55.2%
Distance from 52-week high+72.9%
Market cap (USD)$263.7M
Open South Korea in the interactive screener